PMN · ProMIS Neurosciences Inc.
$14.06
-0.46 (-3.17%)
At close · Jul 29
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“There is no assurance of success in obtaining such additional financing on terms acceptable to us, if at all, and there is no assurance that we will be able to enter into collaborations or other arrangements. If we are unable to obtain funding, it could force us to delay, reduce or eliminate research and development programs and product portfolio expansion or commercialization efforts. These potential delays, reductions and eliminations could adversely affect future business prospects, and our ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$126.09M
Shares
8.97M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$14.06
Open$14.60
Day$13.25–14.60
52W$6.27–27.40
Avg vol 30d146K
Short int236K · 2.6% float · 3.1d
Short vol55%
DataJan 2020–Jul 2026
Filing10-Q · May 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+18%
above
Price vs 50-day avg
+20%
above
RSI (14)
56
neutral
MACD trend
Negative
52-week position
37%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+7%
trailing
6-month return
−10%
trailing
YTD return
+106%
this year
Relative strength
−18%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $12 › 200d $12 — 200d above 50d
Institutional flow
Flat
1 of 25 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.63% of float · ▲ +15.6% MoM · 3.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
25 holders — 13F breadth
Squeeze score
65
elevated · 0–100
Fundamentals
EPS growth
−960%
Y/Y
Free cash flow
$-28.1M
Balance sheet
$6.1M
net cash
Quant / Vol
risk profile
Volatility
99%
annualized · 1-yr
Max drawdown
−68%
past year
ATR
11.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+18%
Bullish
Price vs 50-day avg
+20%
Bullish
RSI (14)
56
Neutral
MACD trend
Negative
Bearish
52-week position
37%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $12 › 200d $12 — 200d above 50d
Institutional flow
Flat
1 of 25 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.63% of float · ▲ +15.6% MoM · 3.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
25 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $6
Now $14 · 37%
52-wk high $27
vs 200-day avg +18%
vs 50-day avg +20%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PMN
this stock
ProMIS Neurosciences Inc.
|
$126.09M | +105.9% | — | — | 2.6% |
|
ONC
BeOne Medicines Ltd.
|
$472.90B | +8.8% | +22179.2% | 962.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +8.2% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +3.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PMN | +0.5% | +6.8% | -10.2% | +6.8% | +105.9% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +1.5% | +6.9% | -17.6% | +7.6% | +97.2% |